AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Dr. Anthony S. Fauci’s Statement on the CAPRISA 004 Microbicide Study

Dr. Anthony Fauci

On July 19, 2010, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, released a statement to acknowledge the results from the CAPRISA 004 Microbicide Study. To read the entire statement, visit the NIAID website. “Today we congratulate the Centre for the AIDS Programme of Research in…

Future Directions for NIAID’s HIV Vaccine Clinical Research

Future Directions for NIAID HIV Research

Co-authored by Margaret I. Johnston, Ph.D., Director of the Vaccine Research Program in NIAID’s Division of AIDS Carl W. Dieffenbach, PhD Margaret I. Johnston, PhD The development of a safe and effective preventive vaccine for HIV remains one of NIAID’s highest priorities. As we look to the future, we are also seeking to expand the…

Looking Ahead: NIAID’s Future HIV/AIDS Therapeutics Priorities

Future Directions for NIAID HIV Research

Since the 1980s when the HIV/AIDS epidemic was first recognized, NIAID-supported clinical research has helped to save millions of lives and played a key role in defining the standard of care for treating HIV infection. This blog post describes what we are seeking for the next wave of HIV/AIDS therapeutic approaches. Specifically, we have identified…

Future Priorities for NIAID’s HIV Prevention Research

Future Directions for NIAID HIV Research

As we begin to discuss the restructuring of NIAID’s clinical trials networks, let us first focus on the Institute’s HIV prevention research agenda. Developing new biomedical tools that can safely and effectively prevent HIV acquisition and transmission is critical to addressing the global HIV/AIDS pandemic. Currently, we are exploring several promising HIV prevention strategies that,…

Restructuring NIAID’s HIV/AIDS Clinical Trials Networks

Future Directions for NIAID HIV Research

Over the next several weeks, the National Institute of Allergy and Infectious Diseases (NIAID) will post a series of entries here on AIDS.gov related to planning for the future of NIAID’s HIV/AIDS clinical trial networks. The awards supporting the six current HIV/AIDS networks are set to expire in 2013 and 2014. Building on the success…

Pursuing a “Cure” for HIV/AIDS – Two Distinct Approaches

Dr. Carl Dieffenbach, PhD

Contrary to what you may have heard or read on the Internet, there is currently no cure for HIV/AIDS. While some say that there may never be a cure, I believe there is reason for hope. That’s because some of our best scientists are working on two distinct approaches to finding a cure for HIV/AIDS,…

Keeping it Real: Understanding the Changing Landscape of HIV/AIDS Clinical Trials Communication

blog.aids.gov

Earlier this month we presented at a symposium of the HIV/AIDS Network Coordination Project’s (HANC) Communications Working Group. We asked Amy Ragsdale, HANC Special Projects Coordinator to tell us a little more about the Working Group and how they are using new media. The HIV/AIDS Network Coordination (HANC) works with the six HIV/AIDS clinical trials…

May 18: HIV Vaccine Awareness Day

blog.aids.gov

May 18, 2010 will mark HIV Vaccine Awareness Day (HVAD), an annual observance day that recognizes the thousands of volunteers, community leaders, health professionals, and scientists that work to develop a safe and effective preventive HIV vaccine. The National Institute of Allergy and Infectious Diseases (NIAID) – the Federal sponsor for HVAD – hopes the…